DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Untch M, Fasching PA, Konecny GE. et al.
Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

J Clin Oncol 2011;
29: 3351-3357

Download Bibliographical Data

Access:
Access:
Access: